| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/20/2004 | US6723832 Isolated peptides corresponding to amino acid sequences of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof |
| 04/20/2004 | US6723830 Short peptides which selectively modulate the activity of protein kinases |
| 04/20/2004 | US6723696 Drug screening for agents to treat hypercalcemia and osteoporosis |
| 04/20/2004 | US6723552 DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| 04/20/2004 | US6723532 Plasmid for use in gene therapy |
| 04/20/2004 | US6723522 For use as an antibody, in expression systems, for measuring activity of the cotransporter, in drug screening and design, or as a reagent for making a probe or a pcr primer, making transgenic animal |
| 04/20/2004 | US6723519 Compositions and method for determining the presence of rat PTTG peptide in a sample |
| 04/20/2004 | US6723511 Suppression of apoptosis in cell; obtain cells, incubate with blocking agent, monitor apoptosis in cells |
| 04/20/2004 | US6723328 A homogenized, killed pure microsporum canis culture provided in a carrier wherein the culture is isolated by filtration. |
| 04/20/2004 | US6723317 Binds to amino acid sequence 1,2 or 4; identification of human papillomavirus (hpv) 16 viral structures |
| 04/20/2004 | CA1341454C Alpha-amidating enzyme compositions and processes for their production and use |
| 04/16/2004 | CA2408207A1 Peptides binding protein phosphatase 2a and polynucleotides coding them |
| 04/15/2004 | WO2004031722A2 Identification of a polypeptide antagonist to the peripheral-type benzodiazepine receptor (pbr) |
| 04/15/2004 | WO2004031400A2 Amyloid beta-derived diffusible ligands (addls), addl-surrogates, addl-binding molecules, and uses thereof |
| 04/15/2004 | WO2004031383A1 High yield heterologous expression cell lines for expression of gene products with human glycosylation pattern |
| 04/15/2004 | WO2004031382A1 Novel method of constructing monoclonal antibody |
| 04/15/2004 | WO2004031368A1 Selection and use of lactic acid bacteria for reducing inflammation caused by helicobacter |
| 04/15/2004 | WO2004031241A1 Monoclonal antibody against subtilisin-like proprotein convertase pace4 and utilization thereof |
| 04/15/2004 | WO2004031105A2 Use of a33 antigens and jam-it |
| 04/15/2004 | WO2004030622A2 Method of isolation and self-assembly of small protein particles from blood and other biological materials |
| 04/15/2004 | WO2004003012A3 Novel variants of the papm polypeptide of bacteria of genus streptomyces |
| 04/15/2004 | WO2003104803A3 Method for mapping and eliminating t-cell epitopes |
| 04/15/2004 | WO2003091266A3 Protein stabilisation using chaperone proteins |
| 04/15/2004 | WO2003070752A3 Mhc-peptide complex binding ligands |
| 04/15/2004 | WO2003068151A3 Human antibodies for therapy against vaccinia or smallpox |
| 04/15/2004 | WO2003059951A3 Novel anti-igf-ir antibodies and uses thereof |
| 04/15/2004 | WO2003020767A9 Antibodies against caspase-8, their preparation and use |
| 04/15/2004 | WO2002059290A8 A method for evolving a cell having desired phenotype and envolved cells |
| 04/15/2004 | WO2002055706A3 Asip-related proteins |
| 04/15/2004 | WO2001070955A8 Identification of essential genes in prokaryotes |
| 04/15/2004 | US20040073012 Monoclonal antibody for diagnosis and treatment of glomerulonephritis, autoimmune and allergic diseases |
| 04/15/2004 | US20040073006 Antibody against norwalk virus and method of detecting virus by using the antibody |
| 04/15/2004 | US20040073004 Comprises Ajuba like protein for diagnosis, prevention and treatment of cell proliferative, cardiovascular and neurodegenerative disease |
| 04/15/2004 | US20040073003 Neuromedin u delta |
| 04/15/2004 | US20040073002 Method for mass-production of target protein by regulating the expression of chaperone protein |
| 04/15/2004 | US20040072999 Novel protein inhibitor of apoptosis proteins |
| 04/15/2004 | US20040072998 Comprises nucleotide sequences coding transient receptor proteins (TRP) for diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents |
| 04/15/2004 | US20040072997 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/15/2004 | US20040072805 Use of tumor necrosis factor inhibitors to treat cardiovascular disease |
| 04/15/2004 | US20040072751 A kits for use in drug screening antagonists, agonists; a recombinant vector polynucleotide, cell culturing, an antibody used for diagnostic, for adjusting the expression of the G protein-coupled receptor protein |
| 04/15/2004 | US20040072747 Novel member of the epha receptor family |
| 04/15/2004 | US20040072340 Use of peptide vectors to improve the immune response to antigens |
| 04/15/2004 | US20040072333 Method of purifying lantibiotics |
| 04/15/2004 | US20040072328 Plasmid shuttle vector between eschelichia coli and bacteria of genus brevibacillus |
| 04/15/2004 | US20040072302 High throughput production of antibodies to genomic derived proteins |
| 04/15/2004 | US20040072300 Comprises expression vector coding cytokines/immunoglobulin fusion protein for treating tumor and autoimmune disorders; immunotherapy; antitumor agents |
| 04/15/2004 | US20040072299 Multiple cytokine protein complexes |
| 04/15/2004 | US20040072294 Generating morphogens associated with extracellular matrix for reconstructing damaged or injured tissues; tissue engineering |
| 04/15/2004 | US20040072293 Comprise genetically engineered peptides for treatment and prevention of gastrointestinal disorders; mimetics |
| 04/15/2004 | US20040072290 Transgenic cells expressing anti-human squamous-cell carcinoma monoclonal antibody with enhanced antibody dependent cellular cytotoxicity (ADCC); drug targeting and delivery |
| 04/15/2004 | US20040072282 Preparing g-protein coupled receptor fragment for identifying modulators of signal tranduction and drug therapeutics |
| 04/15/2004 | US20040072271 Using recombinantly derived antibodies (rVab) to identify unique active surfaces of pharmaceutical targets |
| 04/15/2004 | US20040072238 Integrin binding polipeptide for diagnosis, prevention and treatment of renal failure, thrombosis, osteoporosis, cancers and diabetes |
| 04/15/2004 | US20040072229 Comprises nucleotide sequences coding ligand binding membrane protein for identifying modulator for treatment of kidney, neural, pancreatic or prostate diseases |
| 04/15/2004 | US20040072220 Neurotonin and use thereof |
| 04/15/2004 | US20040072219 Genetically engineered obesity protein with reduced immune response for treatment of diabetes, high blood pressure and cholesterol metabolism disorders |
| 04/15/2004 | US20040072188 Comprises nucleotide sequences coding B-cell activating factor receptor (BAFF-R) for diagnosis, prevention, treatment and/or delay of cancers, lymphomas and autoimmune diseases |
| 04/15/2004 | US20040072172 Comprises enzymatic polypeptide associated with calcium dependent movement of phospholipids through plasmid membranes for diagnosis and treatment of thrombosis, angina pectoris and stroke; gene therapy |
| 04/15/2004 | US20040072169 Comprises nucleotide sequences coding polypeptide for exogenous expression in avian embryonic stem cells; bioreactors |
| 04/15/2004 | US20040072159 Bzip type transcription factors regulating the expression of rice storage protein |
| 04/15/2004 | US20040072152 Screening blood and identifying immunologically active antigen of herpes simplex virus (HSV) which attacks skin; diagnosing viral infection; viricides |
| 04/15/2004 | US20040071738 Hypo-allergenic pollen protein treated with thioredoxin, nicotinamide adenine dinucleotide phosphate- thioredoxin reductase (NTR) and reduced nicotinamide adenine dinucleotide phosphate (NADPH) |
| 04/15/2004 | US20040071737 Polysaccharides and/or glycopeptides preparable from keratinophilic fungi and yeasts; vaccines, immunomodulators, and antiallergens; precipitation and separation of supernatant; treatment with mineral or organic acid |
| 04/15/2004 | US20040071731 Chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 04/15/2004 | US20040071730 Polypeptides and polynucleotides; genetic engineering; medical diagnosis |
| 04/15/2004 | US20040071725 Administered with target antigens to treat infections; anticarcinogenic and antitumor agents; genetic engineering |
| 04/15/2004 | US20040071724 Heat shock protein-based vaccines and immunotherapies |
| 04/15/2004 | US20040071721 A fusion protein of antigen and heat shock protein; DNA therapy promoting gene expression in mammal cells, treating infectious diseases and cancers, tumors; polynucleotide construct vectors |
| 04/15/2004 | US20040071720 A fusion protein of antigen and heat shock protein; DNA therapy promoting gene expression in mammal cells, treating infectious diseases and cancers, tumors; polynucleotide construct vectors |
| 04/15/2004 | US20040071717 Recombinant DNA encoding the major allergen of plantago lanceolata pollen, Pla I 1, and applications thereof |
| 04/15/2004 | US20040071713 A protein is obtained from gene expression of Pseudomonas aeruginosa, molecular weight range from 13 kDa to 80 kDa, purification, antibody, immunization with vaccine antigens, treating bacterial infections |
| 04/15/2004 | US20040071712 Modified peptides as therapeutic agents |
| 04/15/2004 | US20040071711 Imaging, diagnosis and treatment of disease |
| 04/15/2004 | US20040071710 Human monoclonal antibody against hepatitis c virus e2 glycoprotein |
| 04/15/2004 | US20040071709 Corona-virus-like particles comprising functionally deleted genomes |
| 04/15/2004 | US20040071699 An antagonists, or agonists, producing antibodies, used as immunotherapy treating allergy, acquired immune deficiency syndrome, autoimmune diabetes, thyroiditis |
| 04/15/2004 | US20040071697 Reducing epithelial toxicity during cancer therapy |
| 04/15/2004 | US20040071695 Novel g-protein coupled receptor |
| 04/15/2004 | US20040071693 Humanised antibodies |
| 04/15/2004 | US20040071692 Minimizes toxicity to normal tissue; high therapeutic index |
| 04/15/2004 | US20040071688 Reduced or removed potential T cell epitopes |
| 04/15/2004 | US20040071671 Cell therapy method for the treatment of tumors |
| 04/15/2004 | US20040071662 Dendritic cells; methods |
| 04/15/2004 | US20040071658 Vaccine immunotherapy for immune suppressed patients |
| 04/15/2004 | US20040071655 Binding agent |
| 04/15/2004 | CA2501218A1 High yield heterologous expression cell lines for expression of gene products with human glycosylation pattern |
| 04/15/2004 | CA2501091A1 Amyloid beta-derived diffusible ligands (addls), addl-surrogates, addl-binding molecules, and uses thereof |
| 04/15/2004 | CA2498631A1 Use of a33 antigens and jam-it |
| 04/14/2004 | EP1408334A1 Procalcitonin 3-116 |
| 04/14/2004 | EP1408333A2 Diagnosis and treatment of Alzheimer's disease |
| 04/14/2004 | EP1408117A1 Glycoprotein and process for producing the same |
| 04/14/2004 | EP1408050A1 A method of producing glucagon-like peptide 1(glp-1)7-36 and an glp-1 analogue |
| 04/14/2004 | EP1407781A1 Anti-lymphotoxin-beta receptor antibodies as anti-tumor agents |
| 04/14/2004 | EP1407269A2 A method for diagnosing a person having multiple sclerosis |
| 04/14/2004 | EP1407054A2 Expression system |
| 04/14/2004 | EP1407052A2 Method for monitoring and modulating protein folding |
| 04/14/2004 | EP1407044A2 Rna interference mediating small rna molecules |
| 04/14/2004 | EP1407033A1 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
| 04/14/2004 | EP1407030A2 Methods for large scale production of recombinant dna-derived tpa or k2s molecules |
| 04/14/2004 | EP1407023A2 Group b streptococcus antigens and corresponding dna fragments |